Even though MMP proteolytic network alterations are common during the progression of cervical cancer, only upregulation of the expression/activity of MMP-2 (gelatinase A) and/or MMP-9 (gelatinase B) seems to be indicative of a poor prognosis in cervical cancer patients 22,57,58. This evidence concerns the gene MMP9 and cervical carcinoma.